A randomized controlled trial demonstrated a significantly reduced incidence of type 2 diabetes among individuals with ...

The use of metformin, rapamycin, 2-deoxy-D-glucose (2-DG), and pioglitazone can alleviate the condition. In Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), the mTOR pathway is ...

Metformin use may be linked to a lower risk for dementia in patients with type 2 diabetes, a meta-analysis of over 3.4 million participants revealed.

Along with lifestyle changes, metformin can help you get your blood sugar, also called blood glucose, under control. If your blood sugar is not controlled, metformin may not be working for you, and ...

The James Beard Foundation today announced its semifinalist nominees for 2025, officially kicking off restaurant awards season across the country. Widely known as the “Oscars” of the food world, the ...

Participants were aged 20-70 years with a body mass index (BMI) greater than 25 and were not taking any anti-diabetic medication other than metformin. After excluding patients with a range of ...

The study authors concluded that those who take insulin or oral diabetes medications such as glyburide or metformin need very close monitoring. They may need to adjust their dosages. This is because ...

The total price you pay for metformin may also depend on the cost to receive doses at your doctor’s office or clinic. You may also need to obtain prior authorization before your plan will cover ...

Am J Health Syst Pharm. 2007;64(12):1265-1273. Vildagliptin has been shown to be relatively safe in clinical trials; however, long-term evaluation of safety data and clinical experience of the ...

They help manage diabetes by lowering blood sugar levels. The only drug in this class is called metformin, and the FDA approved it in 1994 to treat type 2 diabetes. Doctors also prescribe it off ...

Department of Pharmaceutics, College of Pharmacy, University of Ha’il, Ha’il 81442, Saudi Arabia Medical and Diagnostic Research Center, University of Ha’il, Ha’il 81442, Saudi Arabia Department of ...

People taking metformin had a lower risk of the two most common skin cancers However, Black patients were not protected against squamous cell cancer TUESDAY, Jan. 14, 2025 (HealthDay News) -- A ...